OptiClik, OptiPen and OptiSet insulin pens discontinued

Following the publication of guidance by the National Patient Safety Agency on the reduction of insulin-related errors, Sanofi-aventis is reducing its range of insulin pens to two devices: pre-filled disposable SoloSTAR pens and the reusable ClikSTAR pen.

SoloSTAR and ClikSTAR will be the only insulin pen devices supplied by Sanofi-aventis for the treatment of diabetes
SoloSTAR and ClikSTAR will be the only insulin pen devices supplied by Sanofi-aventis for the treatment of diabetes

The following insulin devices have been discontinued: pre-filled disposable OptiSet, reusable OptiClik and reusable OptiPen Pro 1. In addition, Sanofi-aventis will no longer distribute the reusable Autopen 24. However, this pen will continue to be supplied by Owen Mumford and is compatible with ClikSTAR cartridges.

Patients using one of the discontinued pens can switch to using the available pens without the need to change their insulin as all the preparations will be available in the SoloSTAR and ClikSTAR range. Needles used with the older devices will continue to be compatible with the new pens.

Both the SoloSTAR and ClikSTAR allow users to select 1–80 units of insulin per dose, in 1 unit increments.

Further information: Sanofi-aventis


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases